Intrapulmonary administration of leukotriene B4 enhances pulmonary host defense against pneumococcal pneumonia.
about
Esterified eicosanoids are acutely generated by 5-lipoxygenase in primary human neutrophils and in human and murine infectionThe pivotal role of 5-lipoxygenase-derived LTB4 in controlling pulmonary paracoccidioidomycosisMatrikines are key regulators in modulating the amplitude of lung inflammation in acute pulmonary infection.Obesity and respiratory infections: does excess adiposity weigh down host defense?Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension.A 24-48 h fed Amblyomma americanum tick saliva immuno-proteome.Protective role of 5-lipoxigenase during Leishmania infantum infection is associated with Th17 subsetLeukotriene B4 amplifies NF-κB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression.Disruption of leptin receptor-STAT3 signaling enhances leukotriene production and pulmonary host defense against pneumococcal pneumonia.Leukotrienes target F-actin/cofilin-1 to enhance alveolar macrophage anti-fungal activity.Monocyte chemoattractant protein 1 regulates pulmonary host defense via neutrophil recruitment during Escherichia coli infection.Intrapulmonary administration of leukotriene B(4) augments neutrophil accumulation and responses in the lung to Klebsiella infection in CXCL1 knockout mice.E-prostanoid 2 receptor signaling suppresses lung innate immunity against Streptococcus pneumoniae.Macrophage dectin-1 expression is controlled by leukotriene B4 via a GM-CSF/PU.1 axis.Leukotriene B4 enhances innate immune defense against the puerperal sepsis agent Streptococcus pyogenes.Opposing roles of LTB4 and PGE2 in regulating the inflammasome-dependent scorpion venom-induced mortality.Increased lethality and defective pulmonary clearance of Streptococcus pneumoniae in microsomal prostaglandin E synthase-1-knockout miceThe medicinal chemistry of stable synthetic leukotriene B(3) and B(4) analogues.Obesity: impact of infections and response to vaccines.Pharmacological Targeting of the Host-Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs.Neutrophil derived LTB4 induces macrophage aggregation in response to encapsulated Streptococcus iniae infection.An enzyme that inactivates the inflammatory mediator leukotriene b4 restricts mycobacterial infection.The role of 5-lipoxygenase in Aggregatibacter actinomycetemcomitans-induced alveolar bone loss.Too much of a good thing: How modulating LTB4 actions restore host defense in homeostasis or disease.Macrophage LTB4 drives efficient phagocytosis of Borrelia burgdorferi via BLT1 or BLT2.Ablation of the Leptin receptor in Myeloid Cells Impairs Pulmonary Clearance of Streptococcus Pneumoniae and Alveolar Macrophage Bactericidal Function.Macrophage-derived LTB4 promotes abscess formation and clearance of Staphylococcus aureus skin infection in mice
P2860
Q24604441-3FA46216-9F79-4199-8133-EB76E86D1991Q28297617-95DE9B9B-B502-4E3B-8B64-E83B27F9A536Q30370370-AF5E90D9-6678-43E7-B704-7B4C5DE51D27Q30417265-09950EE2-516E-4867-8F68-73A26965403EQ33593640-D0143C6E-95BF-44E4-9EA2-3B7B2BE9015DQ33906314-C1C34E22-4206-4A20-A744-56EA841DC465Q34306734-B1FD71DB-A663-476B-B9DC-487FF09A09C4Q34519864-C8F1DB53-7650-49AE-966D-3F0D5FD98AFCQ35096769-3967B601-E3AE-4668-B5DF-FE678FBC0139Q35309579-FA722166-4DDD-433D-994B-7C514FA05310Q35329072-346585DD-3FDF-41FD-A407-ABA800ABF6F2Q35851033-982348DE-AC55-4551-AB81-57D5CA448358Q35954130-99ABE9A2-F1B6-4048-A7FF-07D1804DEFADQ36083704-46E96CAA-1382-4FF9-986E-384DB77A8F57Q36586120-9AFD3BE4-576C-4CED-BDF7-38B3EDB529A3Q36615677-DF32BF75-AEE5-4C59-AFAD-57A120A96121Q37071762-4A30A31B-051F-44A1-9958-E0270A4EE8F4Q38014899-64BDE463-8A73-4B57-B7A8-DC1FA66D6B98Q38683577-1964D7C4-E042-44F4-9A0E-270172C3F122Q39173330-5F8B21FB-6A0A-4A10-8300-DF8298A24FD9Q40154916-9236EF36-9770-41AF-8864-81D32C70EFCBQ41818153-38911C82-2D84-4595-8949-1F8BB3022B1DQ48344482-0C8364CD-33C2-470D-AD37-5D31506C9EA9Q50084722-2F543ED1-C96C-4ECE-B03C-FD988CA1B40AQ50318202-A4C4004F-A584-475A-9D1B-9883B2A28B91Q52643046-6D01698C-EA94-4F0E-8B75-6A55E5A38944Q58209773-02522D91-0143-47A6-BF67-0306CEA4829C
P2860
Intrapulmonary administration of leukotriene B4 enhances pulmonary host defense against pneumococcal pneumonia.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Intrapulmonary administration ...... gainst pneumococcal pneumonia.
@en
type
label
Intrapulmonary administration ...... gainst pneumococcal pneumonia.
@en
prefLabel
Intrapulmonary administration ...... gainst pneumococcal pneumonia.
@en
P2093
P2860
P356
P1476
Intrapulmonary administration ...... gainst pneumococcal pneumonia.
@en
P2093
Carlos Henrique Serezani
Casey Lewis
Deepti Goel
Peter Mancuso
P2860
P304
P356
10.1128/IAI.01323-09
P407
P577
2010-03-15T00:00:00Z